REVVITY INC宣布启动创新合作计划，该计划将专项资助参与合作的生物技术企业，使其能够通过REVVITY Signals的Xynthetica服务平台，直接获取制药巨头礼来公司开发的先进预测模型。
这项合作旨在加速生物技术领域的研发进程，通过资金支持降低创新门槛。参与企业将获得技术准入资格，利用礼来经过验证的预测模型优化药物发现流程。REVVITY Signals的Xynthetica平台作为技术枢纽，将为模型部署和应用提供全流程支持。
此次合作凸显了行业领先企业共同推动生物医药创新的承诺。通过资源共享与协同创新，有望为患者带来更高效的疗法，同时为参与方创造新的增长机遇。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.